Elon's $25 Trillion Confession
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.
When self-doubt creeps in at work, pause and reframe your negative thoughts. Here's how
NEW YORK (AP) — When we make mistakes at work, it can lead to a cycle of negative thinking.
History's Playbook Repeats - Ad
Novo, Lilly, Rhythm... each started small. This Canadian peer could follow with needleless peptide delivery.
Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it
WASHINGTON (AP) — When President Donald Trump's administration announced it would as a new treatment for autism, it came as — including the physician who suggested the idea to the nation’s top health officials.
Albertsons recalls several deli items due to potential listeria contamination
NEW YORK (AP) — Albertsons Companies has recalled several of its store-made deli products because they may contain listeria bacteria, in a move that arrives shortly after federal health officials certain pasta meals sold at Walmart and Trader Joe’s over similar contamination concerns.
Timing the Next Health Trend - Ad
Every wave begins small. This one is forming now with first-mover advantage in peptide delivery.
Lawsuit seeks to stop Trump's $100,000 fee for H-1B visas
SEATTLE (AP) — In what appears to be the first major challenge to the new applications, a coalition of health care providers, religious groups, university professors and others filed a federal lawsuit Friday to stop the plan, saying it has “thrown employers, workers and federal agencies into chaos.”
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores
Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings.
October 16: D-Day For The Dollar - Ad
A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on October 16. Investors who make the right moves before then could make up to 40X by 2032...
PepsiCo's new challenge: Making its chips and sodas colorful without artificial dyes
VALHALLA, New York (AP) — Pepsi has a new challenge: keeping products like and vivid and colorful without the that U.S. consumers are increasingly rejecting.
Walmart sets a timeline for removing synthetic dyes and other additives from its food brands
NEW YORK (AP) — said Wednesday that it plans to remove and 30 other ingredients, including some preservatives, artificial sweeteners and fat substitutes, from its store brands sold in the United States by January 2027.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
AnaptysBio Charts Path To Split Into Two Public Companies By 2026
AnaptysBio plans to separate into Royalty Management Co. and Biopharma Co. by 2026, with each positioned for growth in distinct market areas.
Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump
WASHINGTON (AP) — Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.
Electric Bills Keep Rising - Ad
Since 2024, US power costs jumped 6.5%, and analysts warn another 8% nationwide rise by 2030. One small US stock could benefit as more households turn to backup storage.
Bill Nye Reveals His Daily Habits For A Sharper Brain: Crosswords, Cycling, Creative Projects
Bill Nye discusses brain-healthy habits while raising awareness for ataxia, a neurological disease affecting his family.
Travelers bothered by their flight's pollution can pay to reduce it elsewhere. Do offsets work?
So you're booking your flight, and just when you're about to check out, the airline asks if you'd like to pay a little something to offset your share of the flight's pollution. Or, maybe you're an environmentally minded person, and you've heard you can buy these things called carbon offsets.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
58M pounds of corn dogs and sausage-on-a-stick products recalled because wood pieces may be inside
NEW YORK (AP) — About 58 million pounds of corn dogs and other sausage-on-a-stick products are being across the U.S. because pieces of wood may be embedded in the batter, with several consumers reporting injuries to date.
Hims & Hers Powers YieldMax's Latest Options-Based Income ETF
YieldMax ETFs grew its expanding lineup of income-oriented funds on Tuesday with the introduction of the YieldMax HIMS Option Income Strategy ETF (NYSE: HIYY).
Margins Built for Scale - Ad
90%+ gross margins. Subscription potential. Facility ready to produce.
Listeria found in Walmart meatball meals may be linked to deadly fettuccine outbreak
Federal health officials are warning consumers not to eat certain heat-and-eat beef meatball pasta meals sold at Walmart stores because they may be contaminated with listeria bacteria previously linked to a .
Trump to put import taxes on pharmaceutical drugs, kitchen cabinets, furniture and heavy trucks
WASHINGTON (AP) — President said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on Oct. 1.
Celebrity Demand Meets Mass Adoption - Ad
Some stars already use them. Now the door is opening for everyone else.
Moderna Stands By UK As Pharma Giants Criticize Pricing, UK Secures First Onshore mRNA Vaccine Production Centre
Moderna, Inc.‘s (NASDAQ: MRNA) UK chief Darius Hughes defended Britain's drug pricing policies after the country was branded the "worst in Europe."
Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit
CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with UnitedHealthcare insurance company, a unit of UnitedHealth Group Inc. (NYSE:
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care
Privia Health (PRVA) to acquire Evolent Health's (EVH) ACO business for $100M, expanding its value-based care footprint.
Al Gore's satellite and AI system is now tracking sources of deadly soot pollution
NEW YORK (AP) — Soon people will be able to use satellite technology and artificial intelligence to track dangerous soot pollution in their neighborhoods — and where it comes from — in a way not so different from monitoring approaching storms under plans by a nonprofit coalition led by former Vice President Al Gore.
Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Tylenol maker rebounds a day after Trump's unfounded claims about its safety
Shares of Tylenol maker Kenvue bounced back sharply before the opening bell a day after President Donald Trump promoted between Tylenol, vaccines and autism.
FDA Clears Merck's One-Minute Cancer Shot
FDA approves Merck's Keytruda Qlex injection for adults with solid tumors. Merck expects it to be available in the U.S. in September.
History's Playbook Repeats - Ad
Novo, Lilly, Rhythm... each started small. This Canadian peer could follow with needleless peptide delivery.
EMA Backs Amgen Drug For Rare Autoimmune Disorder
European Medicines Agency's panel recommends expanding Amgen's Uplizna to treat IgG4-related disease, with trial data showing reduced flares and higher remission rates.
My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years
Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue.
Timing the Next Health Trend - Ad
Every wave begins small. This one is forming now with first-mover advantage in peptide delivery.
FDA takes aim at Hims and other telehealth services in drug advertising blitz
WASHINGTON (AP) — For the first time, federal health officials are taking aim at promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the on pharmaceutical advertising.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.